|
|
Title:
Hydrogel functionalized with a polymerizable moiety and their uses as
biosensors or bioreactors
United States Patent: 7,737,240
Issued: June 15, 2010
Inventors: Marks; Robert
(Omer, IL), Cosnier; Serge (Crolles, FR), Polyak; Boris (Philadelphia,
PA), Ionescu; Elena Rodica (Judetul Ilfov, RO), Abu-Rabeah; Khalil (Beer-Sheva,
IL)
Assignee: Universite Joseph
Fourier-Grenoble 1 (St. Martin d'Heres, FR), Ben-Gurion University of the
Negev Research and Development Authority (Beer-Sheva, IL)
Appl. No.: 12/041,570
Filed: March 3, 2008
|
|
|
Training Courses -- Pharm/Biotech/etc.
|
Abstract
The present invention relates to a new
hydrogel functionalized with a polymerizable moiety, the polymerized
hydrogels, films and gels comprising the same and their use for cells,
proteins, DNA or other molecules encapsulation, including use as
biosensors or bioreactors.
Description of the
Invention
The present invention
relates to a new hydrogel functionalized with a polymerizable moiety, the
polymerized hydrogels, films and gels comprising the same and their use
for cells, proteins, DNA or other molecules encapsulation, including use
as biosensors or bioreactors.
Biosensors enable direct, sensitive, and rapid analysis of biological and
chemical species and hence are used in many areas of health care and life
science, ranging from uncovering and diagnosing disease, to the discovery
and screening of new drugs and molecules (Cosnier, S. Anal. Bioanal. Chem.
2003, 377, 507-520; Maite, S. Francisco, A. J. Chemical. Reviews. 2003,
104, 3239-3265; Vagdama, P. Crump, P. Analyst. 1992, 117, 1657)
Biosensor devices couple an immobilized biospecific recognition entity to
the surface of a transducer, which `transduces` a molecular recognition
event into a measurable electrical signal, pinpointing to the presence of
the target molecule.
Hydrogel matrices have been widely used to construct biosensors such as
the promising hydrogel alginate, which belong to a family of copolymers
containing 1,4-linked .beta.-D-mannuronic, and .alpha.-L-guluronic acid
residues that vary in both proportions and sequential arrangements
(Torres, L. G. Sanches-de-la-vega, N. A. process Biochem. 1998, 33, 625;
Kierstan, M. Bucke, C. Biotech. Bioeng. 2000, 67, 726; Gombotz, W. R. Wee,
S. F. Adv. Drug Delv. Rev. 1998, 31, 267; Cosnier, S. Novoa, A. Mousty, C.
Marks, R. S. Analytica Chim Acta. 2002, 453, 71-79).
Gels form thereof spontaneously in the presence of divalent ions like
calcium in a single-step process undergone at very mild conditions. The
large technical success in their entrapment and encapsulation is due to
the gentle environment they provide the trapped material, as well as, the
existence of high porosity, due to the open lattice structure in the gel.
This allows for high diffusion rates within the whole gel structure and
facilitates exchanges with aqueous solution. However, precisely due to
this high porosity, macromolecules such as enzymes will leak out into the
aqueous solution, thus, limiting the use of such a matrix to mostly whole
cells or cell organelles (Smidsord, O. Skajak-Barak, G. TIBTECH. 1990, 8,
71; Oretega, N. Busto, M. D. PerazMateos, M. Bioresour. Technol. 1998, 64,
105; Martinsen, A. Skajak, G. Smidsord, O. Biotechnol. Bioeng, 1989, 33,
79; Blandino, A. Mcias, M. Cantero, D. Enzyme. Microb. Technol. 2000, 27,
319).
Several procedures to stabilize alginate gels and reduce their porosity in
order to provide them with the property of controlled-release have been
proposed. The most frequently used methods are polycationic coating
(Schacht, S. Vandichel, J. C. Encapsulation and Controlled Release, Royal
Society of Chemistry, Cambridge, 1993, 18-34) and covalent cross-linking
(Levy, M. C; Edward-Levy, F. J. Microencapsulation. 1996, 13, 169), still
not satisfactory.
The present invention concerns thus a new functionalized hydrogel where an
hydrogel backbone and a polymer are bonded with one or more covalent
bonds, the polymer being formed in situ by polymerization of a
functionalized hydrogel grafted with at least one polymerizable moiety
According to the present invention, "grafted" means a covalent link
between the hydrogel and the polymerizable moiety.
The present invention concerns a functionalized hydrogel backbone grafted
with at least one polymerizable moiety.
Hydrogel backbones are well known in the art, preferably selected among
polysaccharides like alginate, chitosan and agar polymers, proteins like
collagen or synthetic polymers capable of forming hydrogels like
polyethylene glycols (PEG), polyhydroxyethylmethacrylic acid (pHEMA) and
polyacrylic acid.
In preferred embodiments, the hydrogel backbone is selected among the
group consisting of carrageenan, chitosan, hyaluronic acid, cellulose,
alginate polymers, preferably alginate polymers as described above.
When the hydrogel is an alginate polymer, the polymerizable moiety is
preferably grafted on one carboxylic acid group of the alginate polymer.
Polymerizable moieties are known in the art. In a preferred embodiment,
the polymerizable moiety is selected among the group consisting of
thiophene, aniline and pyrrole groups, preferably a pyrrole group.
The functionalized hydrogel according to the invention advantageously
comprises a spacer moiety between the hydrogel backbone and the
polymerizable moiety. Such spacer is selected to avoid substantial
interference with the polymerization process for the polymerizable moiety.
It may be selected among alkylenyl groups, cycloalkylenyl groups,
alkenylenyl groups, eventually substituted by one or more substituents.
According to the present invention, alkenyl groups are preferably C1-C6
linear or branched alkenyl groups, including methylenyl, ethylenyl,
propylenyl, butylenyl, pentalenyl and hexylenyl radicals. The same
definition applies for the alkenylenyl groups, but where it comprises one
or more unsaturated bonds.
Cycloalkenyl groups are preferably C3-C6 cycloalkylenyl groups, including
cyclopropylenyl, cyclopentylenyl and cyclohexylenyl groups.
Both the hydrogel backbone and the polymerizable moiety may be linked to
the spacer on the same carbon atom, or on different carbon atoms.
One or more --CH.sub.2-- or --CH< groups of the spacer may be replaced by
an oxygen, an amino or a carbonyl group.
In preferred embodiments, the polymerizable moiety is grafted to the
hydrogel moiety through an amide bond or an ether bond.
Preferred of these functionalized hydrogels according to the invention can
be represented by the following formulas (1) and (2)
-- see Original Patent.
In preferred embodiment, the functionalized hydrogel according to the
invention comprises an alginate polymer as hydrogel backbone and a pyrrole
moiety as polymerization moiety.
Preferred alginate polymers comprising at least one pyrrole moiety can be
represented by the following formula (3)
-- see Original Patent.
Preferred functionalized
alginate hydrogels comprising at least one grafted pyrrole moiety of the
invention can be represented by the following formula (4)
-- see Original Patent.
Alginate hydrogels grafted
with pyrrole moieties preferably comprise form 10% to 40% of pyrrole
moieties based on the total number of carboxylic acid moieties of the
alginate polymer, more preferably about 30% of pyrrole moieties.
To obtain an hydrogel backbone and a polymer are bonded with one or more
covalent bonds the polymerizable moiety of the functionalized hydrogen of
the present invention is further polymerized.
In situ polymerization of the polymerizable moiety will lead to the
formation of the corresponding polymer covalently bond to the hydrogel
backbone by one or more covalent bonds, such as a polypyrrole polymer.
Additional properties of the functionalized hydrogel of the present
invention are associated with the choice of the polymer being grafted to
the hydrogel backbone.
For instance, a polypyrrole polymer will add specific electrochemical
properties.
The present invention also concerns a method for the preparation of a
functionalized hydrogel as defined above and below, comprising reacting an
hydrogel backbone with a polymerizable moiety functionalized to allow the
formation of a covalent bond between the hydrogel backbone and the
polymerizable moiety.
Formation of a covalent bond between an hydrogel backbone and a
polymerization moiety, eventually through a spacer, will depend on the
chemical structure of the hydrogel backbone and the polymerizable moiety.
Method for such grafting are known in the art.
The method of the invention further comprises polymerizing the
functionalized hydrogel of the invention, under conditions suitable for
the polymerization of the polymerizable moiety.
Such methods are well known in the art. In a preferred embodiment,
polymerization of the polymerizable moiety is done chemically or
electro-chemically.
The present invention also concerns a polymer composition comprising
functionalized hydrogel as defined above and below preferably in the form
of a film or a gel.
The invention also concerns a composition comprising a functionalized
hydrogel of the invention or a polymer composition as defined above and
below combined with at least a second element selected among cells,
proteins, DNA or other molecules. Such composition may be comprised in a
biosensor, in a bioreactor or in a pharmaceutical compositions comprising
a composition defined above and a pharmaceutically acceptable carrier.
The present invention contemplates the use of pharmaceutical formulations
for human medical use which comprise a functionalized hydrogel composition
of the present invention as therapeutic ingredients. Such pharmaceutical
formulations may include pharmaceutically effective carriers, and
optionally, may include other therapeutic ingredients. The carrier or
carriers must be pharmaceutically acceptable in the sense that they are
compatible with the therapeutic ingredients and are not unduly deleterious
to the recipient thereof. The therapeutic ingredient or ingredients are
provided in an amount necessary to achieve the desired therapeutic effect.
The term "carrier" refers to a diluent, adjuvant, excipient, or vehicle
with which the conjugate is administered. Such pharmaceutical carriers can
be sterile liquids, such as water and oils, including those of petroleum,
animal, vegetable or synthetic origin, such as peanut oil, soybean oil,
mineral oil, sesame oil and the like. Water is a preferred carrier when
the pharmaceutical composition is administered intravenously. Saline
solutions and aqueous dextrose and glycerol solutions can also be employed
as liquid carriers, particularly for injectable solutions.
Suitable pharmaceutical excipients include starch, glucose, lactose,
sucrose, gelatin, malt, rice, flour, chalk, silica gel, sodium stearate,
glycerol monostearate, talc, sodium chloride, dried skim milk, glycerol,
propylene glycol, water, ethanol and the like.
The composition, if desired, can also contain minor amounts of wetting or
emulsifying agents, or pH buffering agents.
The compositions can take the form of solutions, suspensions, emulsion,
-tablets, pills, capsules, powders, sustained release formulations and the
like. The composition can be formulated as a suppository, with traditional
binders and carriers such as triglycerides.
Exemplary means of administration include oral, parenteral, rectal,
topical, sublingual, mucosal, nasal, ophthalmic, subcutaneous,
intramuscular, intravenous, transdermal, spinal, intrathecal, intra
articular, intra arterial, sub arachnoid, bronchial, lymphatic, and
intrauterine administration.
Oral formulation can include standard carriers such as pharmaceutical
grades of mannitol, lactose, starch, magnesium stearate, sodium
saccharine, cellulose, magnesium carbonate, etc.
EXPERIMENTAL SECTION
Materials. Chemicals obtained from commercial sources were of analytical
grade and were used without further purification. Sodium alginate Protanal
LF10/60 (from Laminaria hyperborea, 70% G content, average molecular
weight of 128 kDa, Viscosity of the 1% (w/v) solution is 40 cP) was
supplied by FMC Biopolymer (Norway). 1-(2-Cyanoethyl) pyrrole (C9135-2),
lithium aluminum hydride solution (62423), celite (22145),
1-ethyl-[3-(dimethylamino)propyl]-3-ethylcarbodiimide HCl (EDAC; E-1769),
2-[N-morpholino]ethanesulfonic acid (MES) buffer (M-8250), calcium
chloride (C-5426), Polyphenol oxidase (PPO) (EC 1.14.18.1, from mushroom)
with an activity of 3620 U mg.sup.-1 solid, Tris-HCl (T-3253) were
purchased from Sigma and Aldrich Co. (USA). N-hydroxysulfosuccinimide (NHSS;
24510), was acquired from Pierce (Rockford, USA). Diethyl ether (5551550)
was obtained from Frutarom (Israel), While Lithium perchlorate (194711000)
was bought from Acros Organics and Catechol (200-427-5) from ICN
Biomedical GmbH.
Synthesis of N-(3-aminopropyl) pyrrole. A solution of 1-(2-cyanoethyl)
pyrrole (0.02 mol) in anhydrous ether (15 ml) was added dropwise to a
suspension of LiAlH.sub.4 (0.05 mol) in anhydrous ether (150 ml) and the
mixture was refluxed for 10 h. After cooling, the excess of hydride was
destroyed by the successive addition of water (1.7 ml), a solution of 15%
(w/v) NaOH (1.7 ml) and water (5.1 ml). The solution was heated to
40.degree. C. for 2 h and filtered on celite before evaporating to
dryness. A yellow oil was obtained (Naji, A. Cretin. M, Persin, M,
Sarrazin, J. J. Polmer. Sci. 2003, 212, 1-11) with a yield of 91.6%.
.sup.1H-NMR.delta. (CDCl.sub.3): 1.90 (m, 2H, CH.sub.2-2); 2.70 (t, 2H,
CH.sub.2-3); 3.95 (t, 2H, CH.sub.2-1); 6.14 (d, 2H, CH-.beta.; 6.65 (d,
2H, CH-.alpha.). .sup.13C-NMR .delta. (CDCl.sub.3): 35.5 (CH.sub.2-2);
39.7 (CH.sub.2-3). FTIR spectroscopy: the characteristic features of the
N-(3-aminopropyl) pyrrole spectrum are a strong sharp peak at 3370 cm.sup.-1
with a medium shoulder at 3295 cm.sup.-1 that corresponds to the "free"
asymmetrical and symmetrical N--H stretching vibration modes of the
aliphatic primary amines.
Preparation of Pyrrole-Conjugated Alginate. The pyrrole-alginate conjugate
was prepared by adding 50 mg (0.25 mmol) of N-(3-aminopropyl) pyrrole to a
solution of alginate (20 ml solution, 0.25 mmol alginate monomer, 50 mg)
in 0.1 M MES buffer, pH 6.0. The reaction mixture was stirred at room
temperature for 10 min to facilitate a homogeneous dispersion of the
pyrrole reagent in the reaction solution. Then, 13.5 mg g (0.0625 mmol) of
NHSS and 24 mg (0.125 mmol) of EDAC were added (ratios of reagents were
calculated for a theoretical 50% molar modification of the number of
carboxylic groups of alginate). After 3 h at room temperature, the
resulting polymer was dialyzed against doubly deionized water using a
6000-8000 MWCO membrane (314 N. River St. USA). The water was changed
twice a day for three days, after which time the modified alginate was
lyophilized.
Spectroscopic Analysis. For FTIR spectroscopy, polymer samples were
prepared as thin films by dissolving 4 mg/ml of the modified alginate into
doubly deionized water. The resulting solution was poured into a
polystyrene Petri dish and dried in an oven at 50.degree. C. for 24 h to
produce a thin transparent polymer film (Sartori, C.; Finch, D. S.; Ralph,
B.; Gilding, K. Polymer 1997, 38, 43-51). Infrared measurements were
performed in transmission mode on a Bruker Equinox 55 infrared
spectrometer. The FTIR spectra were averaged over 128 scans at a
resolution of 4 cm.sup.-1.
For .sup.13C-NMR spectroscopy, samples of modified alginate were dissolved
in D.sub.2O. .sup.13C-NMR measurements were performed on a Bruker Advance
DNX instrument (500 MHz) utilizing standard Pals programs.
Quantitative Assay of the Extent of Modification of the Alginate. The
modification extent of the alginate by N-(3-aminopropyl) pyrrole was
evaluated by UV absorbance measurements at 230 nm. Pyrrole-alginate
samples were dissolved to produce 0.01% (w/v) alginate solution and
measured using a Ultrospec 2100 Pro UV/Visible Spectrophotometer (Biochrom
CB4 0FJ, England) at 230 nm. The extent of alginate modification was
calculated from the calibration curve obtained by measuring the absorbance
of different amounts of N-(3-aminopropyl) pyrrole into 0.01% (w/v)
alginate solution. A standard solution of alginate at the concentration of
(0.01% w/v) was used as a blank.
Viscosity Measurements. The viscosity of various pyrrole-alginate and
non-modified alginate solutions [1.5-3% (w/v) in doubly deionized water]
was determined using a Carrimed CLS 50 controlled-stress Rheometer (TA
Instruments, UK). The measurements were performed using cone-plate
geometry (4 cm/4.degree.).
HPSEC-MALLS Analysis. Molecular weight distributions of the polymers were
determined with a multi-angle laser light scattering (MALLS) photometer
(DAWN DSP, Wyatt Technology Inc., Santa Barbara, USA), fitted with a K5
flow cell and a He--Ne laser (633 nm). Polymer samples, 3 mg/L, were
prepared in a buffer containing 0.02% (w/v) sodium azide and 0.1 M sodium
nitrate in 10 mM imidazole solution at pH 7.0. Fractional separations were
performed on 100-, 300-, and 1000-.ANG. PSS Suprema separation columns
(Polymer Standard Service, Germany). The mobile phase was delivered at
ambient temperature at a nominal flow rate of 0.7 mL/min. MALLS and
differential refractive index (DRI) detectors were calibrated with
filtered HPLC-grade toluene and NaCl solutions, respectively. The MALLS
instrument was normalized using standard pululan P-23 (isotropic light
scattering). The dn/dc value (specific refractive index increment) for the
studied polymers was estimated at 0.155 [mL/g], according to the value
reported in the literature for sodium alginate in the presence of NaCl..sup.18
Electrochemical instrumentation. All the electrochemical experiments were
carried out in a conventional electrochemical cell (Metrohm). A saturated
Ag--AgCl-saturated KCl electrode was used as a reference electrode and a
Pt wire placed in a separate compartment containing the supporting
electrolyte was used as counter electrode. The working electrode was a
rotating glassy carbon disk electrode (diameter 5 mm) polished with 2 .mu.m
diamond paste (MECAPREX Press PM). The amperometric measurements were
performed in 0.1 M Tris-HCl buffer (pH=6.5) using a Tacussel PRG-DL
potentiostat and an electrochemical cell thermostated at 20.+-.1.degree.
C. The electrochemical control of the amount of enzyme released in the
buffer solution was carried out with an Autolab 100 potentiostat.
The electropolymerization process was performed at room temperature by
controlled potential oxidation for 20 min at 0.94V in 0.1 M LiClO.sub.4
aqueous solution using a potentiostat EG & G Princeton Applied Research
173 equipped with a Model 175 universal programmer in conjunction with a
Kipp and Zonen BD 91 XY/t recorder.
Preparation of enzyme electrodes. A 2% (w/v) aqueous solution of alginate
or pyrrole-alginate was prepared in 0.1M Tris-HCl buffer (pH=6.5) and
stirred overnight at room temperature. The resulting solution was filtered
using a 0.22 .mu.m membrane filter to remove microorganisms and
contaminants.
A 15 .mu.l mixture of 2% (w/v) alginate or pyrrole-alginate containing 75
.mu.g of polyphenol oxidase (PPO) was spread on the surface of glassy
carbon electrodes (diameter 5 mm). The coatings were then gellified by
soaking in 0.1M CaCl.sub.2 for 15 min. The pyrrole-alginate-PPO electrode
was potentiostated at 0.94 V for 10 min to oxidize the pyrrole moieties
into polypyrrolic chains inside the gel.
Results and Discussion
Alginate modification. Pyrrole-alginate was prepared in an aqueous phase
via carbodiimide chemistry according to the scheme shown in FIG. 1 (see Original Patent).
The aqueous-phase carbodiimide chemistry approach uses a water-soluble
carbodiimide (EDAC) that catalyzes the formation of amide bonds between
carboxylic acids and amines by activating the carboxylate to form an O-acylisourea
intermediate (Khorana, H. G. Chem. Rev. 1953, 53, 145-166, DeTar, D. F.;
Silverstein, R.; Rogers, F. F., Jr. J. Am. Chem. Soc. 1966, 88,
1024-1030). This intermediate is unstable in aqueous solution and
undergoes fast hydrolysis. For the procedure to be successful, the active
form of alginate carboxyls would have to be more stable than the O-acylisourea
derivative. Such a condition could be fulfilled by the so-called "active
esters", such as N-hydroxysuccinimidyl esters (NHS) developed for peptide
synthesis (Anderson, G. W.; Zimmerman, J. E.; Callahan, F. M. J. Am. Chem.
Soc. 1964, 86, 1839-1842) or their sulfonated derivatives (Staros, J. V.
Biochemistry 1982, 21, 3950-3955).
The alginate conjugation chemistry was designed to obtain about 25-35%
modification of the molecule to keep about 70% of the carboxylic residues
non-modified and available for its cross-linking by calcium. According to
our previous study (Polyak, B.; Shimona, G; Marks, R. S. Biomacromolecules.
2004, 5, 389-396) and other studies (Rowley, J. A.; Madlambayan, G.;
Mooney, D. J. Biomaterials. 1999, 20, 45-53) with biotin-alginate
modification, the reaction efficiencies were about 70%, therefore a 50% of
uronic acid activation chemistry was used for achieving the desired degree
of alginate modification. The coupling procedure was performed using the
previously described optimal reaction conditions.
Control reactions without the addition of EDAC for activation were run for
each experiment. After dialysis, less than 1% of pyrrole moiety was
detected by UV spectroscopy, suggesting that the incorporation of pyrrole
is not a result of nonspecific interactions or physical entrapment of
N-(3-aminopropyl) pyrrole by the polysaccharide.
Spectroscopic Characterization of Pyrrole-Alginate. The pyrrole-alginate
product was characterized by FTIR and .sup.13C-NMR spectroscopy. The
characteristic features of the pyrrole-alginate spectrum are strong sharp
peaks at 1666 cm.sup.-1 and at 1560 cm.sup.-1 which correspond to the
amide I band, C.dbd.O stretching vibrations, and amide II band, N--H
bending vibrations respectively, and a medium-sharp peak at 1282 cm.sup.-1
(amide II band, interaction between the N--H bending and C--N stretching
vibrations) (Silverstein, R. M.; Webster, F. X. Spectrometric
Identification of Organic Compounds, 6th Edition, 1997).
The .sup.13C-NMR spectrum confirmed the conjugation of pyrrole to alginate
via the formation of an amide bond. In contrast to the chemical shift of
the carboxyl group at 174.1 ppm present in the non-modified alginate, the
pyrrole-alginate product showed two new chemical shifts, that of 1-amide
carbonyl (CONH) at 174 ppm and that of a carbon on the pyrrole ring (CHN)
at 121.6 ppm.
Quantification of the pyrrole Content in the Modified Alginate. The extent
of modification of alginate by N-(3-aminopropyl) pyrrole was evaluated by
UV-visible absorption spectroscopy, which is a useful technique for the
detection and quantitative measurements of chromophores that undergo
n.fwdarw..pi.* or .pi..fwdarw..pi.* transitions. Because of its
sensitivity, UV-visible spectroscopy had been particularly useful in
identifying and analyzing "foreign" material in polymers-residual monomer,
inhibitors, antioxidants and so on..sup.33-34. A .pi..fwdarw..pi.*
transition occurs in the pyrrole ring present in the pyrrole-alginate
conjugate allowing the quantification of the amount of N-(3-aminopropyl)
pyrrole by UV-visible absorption spectroscopy at 230 nm. Several samples
within a concentration range (50-250 .mu.M) of N-(3-aminopropyl) pyrrole
dissolved in alginate solution (0.1 w/v %) were measured by UV absorption
at 230 nm. The data collected from UV-absorbance measurements had a very
good linear range for the studied N-(3 aminopropyl) pyrrole concentrations
(R.sup.2=0.99). The extinction coefficient of 2080 M.sup.-1 cm.sup.-1 for
N-(3 aminopropyl) pyrrole was calculated from the slope of the plotted
curve.
The average value of the degree of alginate modification obtained about
30.+-.3% of molar modification for a number of samples related to
different synthetic bathes of the pyrrole-alginate conjugate. The
relatively low standard deviation indicates a good reproducibility of the
modification procedure of the alginate.
Characterization of Molecular Weight Parameters and Viscosity.
Differential molar mass distribution shows how much material (differential
weight fraction) is present in any molecular weight interval. Cumulative
distribution gives, for each molar mass, the weight fractions of material
having molar mass less than the given weight. Thus, the cumulative
distribution approaches zero at low molecular weights and unity at high
molecular weights. The cumulative distribution is thus particularly useful
in determining which molecular weight fractions are contained in the high
and low molecular tails of the sample (Tristan, T., Hugo, G. J. Agric.
Food. Chem. 2000, 48, 5455-5458). The pyrrole-alginate product shows a
clear shift to higher molecular weights in both distribution
presentations.
This result of the light scattering provides a method for determining
absolute molecular weight and size distribution (Debye, P. J. W. J. Appl.
Phys. 1944, 15, 338-342), which implies that pyrrole, is probably
distributed homogeneously on the alginate backbone. The weight-average
molecular weight (M.sub.w) for pyrrole-alginate (30.+-.3% molar
modification) was measured as 370-390 kDa (M.sub.w/M.sub.n=3.03-3.4) by
means of SEC. This value represents an increase from the initial M.sub.w
of alginate (M.sub.w=128 kDa, M.sub.w/M.sub.n=1.14). The ratio M.sub.w/M.sub.n
is a measure of the dispersivity of the polymer chains. The meaning of the
wide ratio of M.sub.w/M.sub.n for pyrrole-alginate and alginate is that we
have poly-dispersed polymers.
The viscosity of pyrrole-alginate solutions at various concentrations
showed that the viscosities were higher than that of the original alginate
solution (Table 1 (see Original Patent)).
This finding reflects the increase of the molecular weight of the modified
alginate relative to the original alginate as well as the increase in the
hydrophobic character of the modified alginate due to the organic pyrrole
moieties.
The carboxylic group interactions in the alginate monomer increase the
steric hindrance affecting the distance between the chains of the
polymers, which lead to the reduction in the shear forces and viscosity
reduction of the solution of the regular alginate compared to the pyrrole-alginate
solutions, where the chemical modification of the carboxylic group of the
monomer by N-(3-aminopropyl) pyrrole leads to less interactions, higher
stability of the hydrogel and high viscosity.
Biosensor Construction.
To characterize the impact of the in situ-electrogenerated polypyrrole
skeleton on the retention properties of the alginate gel, the phenomenon
of enzyme release or loss was investigated for regular alginate and
polypyrrole-alginate. Polyphenol oxidase (PPO) which catalyzes the
oxidation of phenols and o-diphenols with a concomitant consumption of
oxygen was chosen an enzyme model. The two biosensor configurations:
alginate-PPO and polypyrrole-alginate-PPO were soaked separately in 0.1 M
Tris-HCl buffer (pH=6.5) for 15 min at room temperature. The enzyme
leakage in solution was estimated amperometrically from their activity
towards the oxidation of catechol. A bare glassy carbon electrode was thus
potentiostated at -0.2V vs Ag/AgCl and the reduction current of the
enzymatically-generated quinone was recorded after the addition of
catechol (2 mM).
The comparison of the linear part of the slope of current vs. time curve
with the slope obtained using the same conditions in presence of free PPO
molecules indicated that 20% (15 .mu.g) and 60% (45 .mu.g) of the initial
entrapped PPO molecules were lost from polypyrrole-alginate and alginate
coatings, respectively. This unambiguously demonstrates the beneficial
effect brought by the polymerization of the pyrrole moieties chemically
grafted on alginate gel on the enzyme retention properties of the
resulting gel.
In-situ electrogenerated polypyrrole seems to act as an additional
polymeric binder that reinforces the stability of the alginate gel.
Moreover, the analytical characteristics of polypyrrole-alginate-PPO and
alginate-PPO electrodes for the determination of catechol were
investigated by potentiostating both biosensors at -0.2V in order to
reduce the quinone enzymatically generated within the gels. The
steady-state current-time response to catechol injections indicates short
response time (20 s) for both biosensor configurations illustrating the
excellent permeabilities of these alginate gels. The resulting calibration
curves led to sensitivity value (determined as the slope of the initial
part of the calibration curve) to catechol of 350 and 80 .mu.AM.sup.-1
cm.sup.-2 for polypyrrole-alginate and alginate biosensors respectively.
In addition, the maximum current value (I.sub.max) for polypyrrole-alginate
biosensor (42 .mu.A cm.sup.-2) was 4.4 times higher than that recorded for
alginate biosensor (9.5 .mu.A cm.sup.-2). It should be noted that
I.sub.max is directly related to the available amount of immobilized
enzyme. These results corroborate the major role played by the in situ
generated polypyrrole for the retention of immobilized enzyme molecules
with preservation of their activity.
Electrode Functionalization
For the functionalization of the electrode, 3 .mu.l of 2% (w/v) aqueous
solution of alginate or pyrrole-alginate was spread on the electrode
surface (carbon disk, diameter 5 mm) and left to react with a drop of 0.1
M CaCl.sub.2 for 5 min.sup.16,17. In order to demonstrate the possibility
to electrochemically polymerize the pyrrole moities grafted on the
alginate skeleton in its gel form and the influence of the resulting
polymer on the physical properties of the alginate coating, the mass
transfer through different alginate gels was examined by cyclic
voltammetry. The permeation of ferrocene dicarboxilic (2 mM) in 0.1M
Tris-HCl (pH=7) through alginate and pyrrole-alginate coatings was thus
illustrated by its one-electron oxidation at the underlying electrode
surface. The presence of these gel coatings led to a similar and marked
decrease in the intensity of the reversible peak system compared to the
signal recorded at a bare electrode. Both gels were then oxidized by
controlled potential electrolysis in H.sub.2O+0.1 M LiClO.sub.4 for 10 min
at 0.93 V versus a saturated Ag--AgCl--KCl electrode (Ag/AgCl). The
expected pyrrole-alginate polymerization was indeed highlighted via the
strong decrease (-70%) in the intensity of the oxidation peak of ferrocene
derivative compared to its initial value (34 .mu.A) before the
electropolymerization process. This increase in diffusional resistance
reflects the formation of polymerized chains within the gel structure. In
contrast, the cyclic voltammogram relative to the oxidized regular
alginate showed an increase in current intensity from 32 .mu.A to 42 .mu.A.
This may reflect a partial loss of alginate gel into the solution during
the polymerization step illustrating thus the unstability of the coating.
In order to confirm the existence of a polypyrrole network in the case of
the oxidized pyrrole-alginate, which would be capable of reinforcing the
gel stability, a polymer elimination step obtained by the organic washing
and chemical destabilization (soaking for 10 min in stirred 95% (v/v)
ethanol solution followed by 10 min in 0.1 M phosphate buffer (pH=7)) was
carried out to remove the alginate coating from the electrode surface. In
the case of polypyrrole-alginate, an increase in the oxidation peak was
observed reaching 50% of the intensity value recorded at a bare electrode
whereas an electrochemical signal identical to that displayed at a bare
electrode, was recorded for regular alginate. This comparison clearly
demonstrates the beneficial effect brought by the electropolymerization
process on the stability of the alginate coating. In particular, the
presence of the polymerized network inside the gel seems to counterbalance
the destructive effect of phosphate ions that normally would induce a
displacement of the gelling agent CaCl.sub.2.
In order to corroborate the presence of polypyrrolic chains within the
alginate gel, the permeabilities of alginate and polypyrrole-alginate
coatings were determined by rotating-disk electrode experiments (RDE) that
were carried out at different rotation rates in the presence of
hydroquinone (1 mM) in 0.1M Tris-HCl (pH=7). The large difference in
permeability values, respectively 3.65.times.10.sup.-1 and
2.7.times.10.sup.-2 cm.sup.-2 s.sup.-1 for alginate and polypyrrole-alginate,
reflects unambiguously the steric hindrances due to the <<in situ>>
generated polypyrrolic chains.
Besides the stabilization of alginate coating, another useful property
would be the possibility of firmly entrapping proteins such as in the
fabrication of enzyme sensors. The ability of polypyrrole-alginate to
retain proteins was investigated with glucose oxidase (GOx) (chosen as a
model) for its ability to catalyse the production of electroactive
H.sub.2O.sub.2 in the presence of glucose and oxygen. The release of GOx
molecules can be evaluated amperometrically through the oxidation of the
enzymatically generated H.sub.2O.sub.2. For this purpose, two separate
types of enzyme coatings were prepared by spreading on the electrode
surface (diameter 5 mm) a mixture containing 15 .mu.l of either alginate
or pyrrole-alginate and GOx (75 .mu.g) followed by the incubation with
CaCl.sub.2 (0.1 M) for 5 min. As previously described, the
polypyrrole-alginate-GOx electrode was obtained by electropolymerization
at 0.93 V (Aubree-Lecat, C. Hervagault, A. Delacour, P. Beaude, C.
Bourdillon and M. H. Remy, Anal. Biochem. 1989, 178, 427).
The resulting electrodes were soaked in 2 ml of stirred 0.1M Tris-HCl
buffer (pH 7) solution for one hour. The release of GOx molecules with
time was periodically followed by sampling the exudates by electrochemical
determination Aliquots (100 .mu.l) after 5, 10, 30, 45 and 60 min were
injected into a phosphate buffer (10 ml, pH 7) containing glucose (50 mM)
and the increase in H.sub.2O.sub.2 concentration was recorded through its
oxidation at a platinum electrode potentiostated at 0.6 V. The linear part
of the slope of anodic current vs. time curve was compared with that
obtained using the same conditions in presence of a known amount of Gox.
It appears that the enzyme release decreases with time reaching a stable
value after one hour. Thus, 40% (30 .mu.g) and 12% (9 .mu.g) of the
initially entrapped amount of GOx molecules were lost from alginate and
polypyrroles-alginate films respectively. This clearly demonstrates a
better retention of enzyme molecules within polypyrrole-alginate hydrogels
thanks to the additional polymeric cross-linking.
Finally, amperometric glucose biosensors were designed by incorporating
GOx (15 .mu.g) into alginate or polypyrrole-alginate hydrogel coatings (3
.mu.l). The resulting enzyme electrodes were potentiostated at 0.6 V and
their amperometric response to glucose was recorded in 0.1M Tris-HCl
buffer (pH=7). Amperometric measurements were performed with a
electrochemical cell thermostated at 25.degree. C. under stirred
conditions in 10 ml (0.1 M Tris-HCl, pH 7) and stock solutions of glucose
were mutarotated at room temperature for 24 h before use.
The calibration curves representing the biosensor response as a function
of glucose concentration, indicate for both configurations that the
current increased linearly with glucose concentration, while a pseudo
plateau was reached at higher concentrations. As expected, the comparison
of the biosensor performance in terms of maximum current (I.sub.max) and
sensitivity values shows that the polypyrrole-alginate coating provided
higher I.sub.max (1.11 .mu.A) and sensitivity (122 .mu.AM.sup.-1) values
than those obtained with the alginate electrode, namely 0.62 .mu.A and 34
.mu.AM.sup.-1. This confirms that the polymerization process which induced
a higher retention degree of GOx molecules, contributes to the improvement
of the biosensor performance.
The influence of the amount of electrodeposited polypyrrole-alginate-GOx
coating on the analytical characteristics of the enzyme electrode was also
investigated. After the successive gellification and electropolymerization
processes of 3 and 15 .mu.l of pyrrole-alginate-GOx mixtures, the
analytical performances of the biosensors were determined. Both biosensors
presented similar kinetic behaviour illustrated by an identical value of
Michaelis-Menten constant (12 mM) and a fast response time (4 s).
However, higher I.sub.max and sensitivity values (4.17 .mu.A and 600 .mu.AM.sup.-1,
respectively) were obtained with the polypyrrole-alginate biosensor
corresponding to 15 .mu.l. It should be noted that a similar ratio (4-5)
was calculated from the comparison of the I.sub.max and sensitivity
values. This factor is in good accordance with the ratio (5) of the
deposited amounts of GOx, illustrating thus, the reproducibility of the
improvement effect due to the polypyrrole network.
The results described herein demonstrate, for the first time, the
electrochemical polymerizing abilities of an alginate polymer
pre-deposited under its gel form on an electrode surface and its
usefulness in reinforcing the mechanical and chemical properties of the
alginate gel. The polypyrrole-alginate may thus constitute an attractive
electrogenerated coating for the immobilization of enzymes.
Claim 1 of 29 Claims
1. A functionalized hydrogel backbone
grafted with at least one polymerizable moiety, wherein the hydrogel is an
alginate polymer, and the polymerizable moiety is grafted on one
carboxylic acid group of the alginate polymer comprising from 10% to 40%
of pyrrole moieties based on the total number of carboxylic acid moieties
of the alginate polymer. ____________________________________________
If you want to learn more
about this patent, please go directly to the U.S.
Patent and Trademark Office Web site to access the full
patent.
|